SCHEMBL1629175

SCHEMBL1629175

O=C(Nc1ccccc1-n1nccc1-c1ccc(O)cc1O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
ABCB1 P08183 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
HDAC1 Q13547 4/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC3 O15379 1/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.40
KCNMA1 Q12791 2/20 0.40
SIRT6 Q8N6T7 1/20 0.39
SCN9A Q15858 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630352 0.93 HDAC1 (0.45) TYRTP53HSP90AA1ABCG2HDAC1
SCHEMBL1629234 0.91 HDAC1 (0.50) SMN1; SMN2TP53ABCG2HDAC1HDAC2
SCHEMBL1631613 0.84 HSP90AA1 (0.46) SMN1; SMN2PLA2G1BATG4BHSP90AA1ABCB1
SCHEMBL1629709 0.84 KCNQ2 (0.51) SMN1; SMN2ALDH1A1MAPTTSHRNPSR1
SCHEMBL1629510 0.82 TYR (0.48) TYRSMN1; SMN2TP53POLBMAPT
SCHEMBL1630445 0.80 POLB (0.48) TYRPOLBALDH1A1MAPTHPGD
SCHEMBL5169471 0.79 ALOX15 (0.41) TYRHSP90AA1MAPTUSP2HSD17B10
SCHEMBL1630006 0.78 MAPT (0.45) HSP90AA1POLBALDH1A1MAPTTSHR
SCHEMBL15049636 0.78 GAA (0.45) HSP90AA1ALDH1A1MAPTUSP2HPGD
SCHEMBL1631545 0.76 HSP90AA1 (0.47) TYRHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P TYR 1637/4885SMN1; SMN2 3103/4885PLA2G1B 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.